Edition:
United States

Biogaia AB (BIOGb.ST)

BIOGb.ST on Stockholm Stock Exchange

385.50SEK
10:21am EDT
Change (% chg)

0.00kr (+0.00%)
Prev Close
385.50kr
Open
383.00kr
Day's High
386.50kr
Day's Low
381.50kr
Volume
4,492
Avg. Vol
27,628
52-wk High
459.50kr
52-wk Low
278.50kr

Summary

Name Age Since Current Position

Peter Rothschild

68 2018 Chairman of the Board

David Dangoor

69 2018 Vice Chairman of the Board

Margareta Hagman

51 2010 Executive Vice President Accounting, Finance and Investor Relations

Urban Strindlov

53 2010 Executive Vice President, Sales Director

Katayoun Welin-Berger

49 2016 Vice President Operations

Ulrika Kohler

51 2016 Vice President Marketing and Product Development

Helen Olsson

52 2015 Vice President Human Resources

Kristina Magnusson Borg

56 2016 Vice President Discovery and Research

Nigel Titford

44 2016 Vice President Business Development

Axel Sjoblad

51 2016 Managing Director

Isabelle Ducellier

49 2018 Director

Peter Elving

70 2018 Director

Ewa Bjorling

57 2015 Independent Director

Inger Holmstrom

69 2007 Independent Director

Anthon Jahreskog

38 2015 Independent Director

Brit Stakston

56 2014 Independent Director

Biographies

Name Description

Peter Rothschild

Mr. Peter Rothschild has been Chairman of the Board of Directors of BioGaia AB since April 25, 2018. He was Group President at the Company from March 1, 2016. He no longer serves as Chief Executive Officer of the Company, effective as of March 1, 2016. He is also Founder and principal shareholder of the Company. He is Working Chairman of the subsidiaries TwoPac AB and CapAble AB as well as the associated company MetaboGen AB. He also serves as Chairman of the Board of Directors of Infant Bacterial Therapeutics AB (IBT) and with board assignments in Looft Industries AB and Stiftelsen Allbright. He holds a Master of Business Administration degree.

David Dangoor

Mr. David E. R. Dangoor has served as Vice Chairman of the Board of Directors of BioGaia AB since April 25, 2018. He was Independent Chairman of the Board of Directors of the Company from April 24, 2007. He has been Member of the Company's Board of Directors since 2003. He is Member of the Company's Remuneration and Nominating Committees. He is Marketing and Public Relations Consultant. He also serves as President of Innoventive Partners LLC. He previously served as Vice President and Director of Marketing of Philip Morris USA and Philip Morris International, and as Chairman of Swedish-American Chambers of Commerce between 1997 and 2001. He also serves on the Boards of Directors of Medical Research, Manhasset, New York, New York City Ballet Inc., School of Creative Leadership, Berlin University and the Swedish-American Chamber of Commerce, among others. Mr. Dangoor holds Master of Business Administration degree.

Margareta Hagman

Ms. Margareta Hagman has served as Executive Vice President Accounting, Finance and Investor Relations at BioGaia AB since April 1, 2010. She was previously Controller at the Company. She has been employed at the Company since 1996. She holds board assignments in the subsidiary TwoPac AB and in Infant Bacterial Therapeutics (IBT) AB. She holds a Master of Business Administration degree.

Urban Strindlov

Mr. Urban Strindlov has served as Executive Vice President and Sales Director at BioGaia AB since 2010. He was previously Senior Vice President of Oral Health Division at the Company. He has been employed by the Company since 2004. He is Mechanical Engineer.

Katayoun Welin-Berger

Ms. Katayoun Welin-Berger has served as Vice President Operations at BioGaia AB since 2016. She has previously been Head of Strategic Purchasing and Quality at BioGaia AB. She has been employed at the Company since 2014. She holds a Doctorate of Philosophy degree in Pharmacology.

Ulrika Kohler

Ms. Ulrika Kohler has served as Vice President Marketing and Product Development at BioGaia AB since 2016. She has previously been Head of Business Unit New Business at BioGaia AB since 2013. She holds a Bachelor of Science degree in Biology with extended studies in microbiology.

Helen Olsson

Ms. Helen Olsson has been Vice President Human Resources at BioGaia AB since June 1, 2015. She has been employed at the Company as a Consultant since 2013. She has studied Human Resources Management.

Kristina Magnusson Borg

Ms. Kristina Magnusson Borg has been Vice President Discovery and Research at BioGaia AB since 2016. She has previously been Clinical Research Director Pediatrics and Female Health at BioGaia AB since 2015. She holds Master of Science in Nutrition/Biochemistry, Ph. Lic. in Clinical Physiology and MBA degree.

Nigel Titford

Mr. Nigel Titford has served as Vice President Business Development at BioGaia AB since 2016. He has previously been Head of Business Unit Adult Health at BioGaia AB since 2014. He holds a Master of Science degree in Business Administration and Business Law. He has been employed by the Company since 1999.

Axel Sjoblad

Mr. Axel Sjoblad no longer serves as Managing Director of BioGaia AB effective as of June 30, 2018. He has held the position since March 1, 2016. He was Managing Director of Getinge Sverige AB and Vice President North and Central Europe and was previously Regional VP Northern European Markets at Gambro Lundia AB. He has experience in marketing and sales. He holds Master of Business Administration and Executive Master of Business Administration, Stockholm School of Economics. He holds board assignments in the subsidiary TwoPac AB and in Vigmed AB.

Isabelle Ducellier

Ms. Isabelle Ducellier has been Director of BioGaia AB since April 25, 2018 and she has been appointed Managing Director of the Company effective as of November 5, 2018. She has a Masters in International Marketing from EM in Lyon and an Executive MBA General Management GMP20 from Harvard Business School. She has twenty-five years’ international experience in Fast Moving Consumer Goods. Among other things she has been Managing Director and Board member of Pernod Ricard Sweden for several years and has been on the boards of a number of companies. She is currently General Secretary of the Swedish Childhood Cancer Foundation. Isabell Ducellier holds 38 Class B shares in BioGaia.

Peter Elving

Ewa Bjorling

Ms. Ewa Bjorling has served as Independent Member of the Board of Directors of BioGaia AB since May 7, 2015. She is Doctor of Dentistry and Doctor of Medicine as well as Associated Professor at Karolinska Institute. Ewa Bjorling was also member of the Swedish Riksdag and the Minister for Trade in the Swedish government from 2007 to 2014. She also served as Minister for Nordic Cooperation from 2010 until 2014. She is Board Member of SCA, Mobilaris AB, KAK, Rehnman & Partners Global Assessment advisory board.

Inger Holmstrom

Ms. Inger Holmstrom has served as Independent Member of the Board of Directors of BioGaia AB since April 24, 2007. She also serves as Senior Partner of Priority. She previously served as Corporate Communications Director at Coop Norden, Posten and Vattenfall. She is Board Member of Jarna akademi. She holds a Master of Arts degree in Language and Linguistics, and a degree in Journalism.

Anthon Jahreskog

Mr. Anthon Jahreskog has served as Independent Member of the Board of Directors of BioGaia AB since May 7, 2015. He was Chief Operating Officer of Fund Linked Products at Credit Suisse Investment Bank, London. He has several years of experience from the international financial market and expertise in strategic business planning, cost efficiency and analysis. He holds a Master of Science degree in Financial Management.

Brit Stakston

Ms. Brit Stakston has been Independent Director of BioGaia AB since May 6, 2014. She is Communication Consultant, Media Strategist and owner of PR Agency Stakston AB. She also founded the reportage site Blankspot. She is Member of Presstodsnamnden.